Cancer Epigenetics and Nanomedicine

Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. Dr. Chitra Thakur is an Assistant Professor-Research in the Department of Pathology at the Stony Brook Cancer Center, New York, USA. She is a cancer biologist and has expertise in molecular oncology, mouse models of human cancers, analyzing big data in translational research, toxicology, and epigenetics in human cancers. She is the recipient of several internationally acclaimed awards such as the “DFG German Excellence Initiative Award,”, “NIH-Big Data Training for Translational Omics Research” and “American Cancer Society IRG”. With more than 45 research articles published in mainstream scientific journals, she has contributed significantly towards the understanding of the molecular mechanisms in human cancers. She is engrossed in cancer research, teaching, and community outreach initiatives, hence fostering the scientific community and health care professionals engaged in cancer diagnosis, and treatment.

Overview of Cancer, Internal and External Factors Associated with Cancer 1. Overview of Cancer: Mechanism of Carcinogenesis Uttara Saran and Chitra Thakur 2. Tumor metabolism and micro-nutrients: New insights to target malignant tumors Santhi Latha Pandrangi, Sireesha V. Garimella, and Prasanthi Chittineedi 3. Inflammation and cancer: An insight Suchandrima Saha, Monisankar Ghosh 4. Environmental Causes of Cancer Priya Wadgaonkar 5. Cancer stem cells: challenges for cancer therapies Rashi Arora and Apoorva Uboveja 6. Carving a therapeutic niche for metastatic cancer: opportunities and challenges Sireesha V. Garimella Epigenetics and its Importance in Cancer Therapies 7. An overview on the epigenetics and cancer Rajendra Prasad Pangeni 8. Causes and Consequences of Variable Tumor Microenvironment on Tumor Evolution Jowana Obeid and Mehdi Damaghi 9. Understanding epigenetics in cancer stem cells and chemoresistance Prajakta Oak and Chitra Thakur 10. Cancer Biomarkers: Where Genetics Meets Epigenetics Snehal Nirgude, Jennifer M. Kalish 11. Epigenetics Approach in Cancer Treatment with Focus on Lung and Breast Cancer Sayani Bhattacharjee 12. Epigenetic diets and drugs in cancer prevention and treatment Chitra Thakur and Uttara Saran Nanomedicine Targeting Epigenetic Machinery in Cancer Therapy 13. Nanotechnology and its relevance in cancer therapies Nur Khatijah Mohd Zin 14 Epigenetic modulation by biosynthetic nanomaterials from plants in cancer Ritu Karwasra 15 Nanotechnology augmented Immunotherapy for cancer Akshata R. Naik 16 Nanoparticles in metastatic cancer treatment Prashant Kesharwani 17 Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer Somaye Akbari, Yeganeh Modirrousta 18. Nanomedicine and Epigenome: possible health risks, benefits, and future Nitin Verma 29. Smart Cancer Nanomedicine: Challenges and Future Opportunities Moumita Roy